Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)

Ozkan, M.Cicin, I.Ozaslan, E.Benekli, M.Oksuzoglu, B.Kocer, M.Isikdogan, A.2024-06-122024-06-1220150959-80491879-0852https://doi.org/10.1016/S0959-8049(16)30707-9https://hdl.handle.net/20.500.14551/25712European Cancer Congress -- 2015 -- Vienna, AUSTRIA[Abstract Not Available]en10.1016/S0959-8049(16)30707-9info:eu-repo/semantics/closedAccess[No Keywords]Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)Conference Object51S245S245Q1WOS:000361887401113